The implementation of the Companies Act, 2013, marked a fundamental transformation in corporate social responsibility practices within Indian pharmaceutical companies, converting CSR from voluntary ethical initiatives to mandatory legal obligations. This research critically examines how pharmaceutical companies have adapted their CSR strategies following the statutory mandate requiring 2% of average net profits to be invested in social development activities. Through comprehensive analysis of 45 pharmaceutical companies and primary research involving 200 industry stakeholders, this study investigates the evolving dynamics between corporate conscience and legal compulsion in shaping CSR governance structures.
Our findings reveal three distinct CSR implementation models emerging post-2013: compliance-driven approaches focused primarily on meeting legal requirements, strategic-integration models that align CSR with business objectives, and conscience-led initiatives that exceed mandatory expectations. While legal mandates have ensured baseline CSR expenditure of approximately ₹2,847 crores annually by pharmaceutical companies in 2023-24, questions persist regarding the authentic impact versus mere compliance-driven spending. The research demonstrates that companies adopting strategic-integration approaches achieve superior outcomes in both social impact metrics and long-term financial performance.
However, significant challenges remain, including concerns about drug pricing accessibility, sustainable healthcare infrastructure development, and genuine community engagement versus tokenistic CSR activities. The study contributes to existing literature by developing a comprehensive framework for evaluating CSR effectiveness in the pharmaceutical sector and provides practical recommendations for enhancing governance structures to balance legal compliance with meaningful social impact.
Keywords: Corporate Social Responsibility, Companies Act 2013, Pharmaceutical Industry, Corporate Governance, Healthcare Access, Regulatory Compliance, Social Impact
How to cite this article: Singh S, Roy S, Corporate Conscience Or Compulsion? A Critical Review Of CSR And Governance In Pharmaceutical Companies Post 2013. Int J Drug Deliv Technol. 2026;16(2s): 764-778; DOI: 10.25258/ijddt.16.764-778